Info

🌱 來自: Metastatic Colon Cancer

TRIBE

• 12.1 months in the experimental group, as compared with 9.7 months in the control group
• Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer | NEJM